Aktieanalys

Vertseit Q4: High Sales and Cost – EBITDA-CAPEX 5% Above Expectations - Redeye

{newsItem.title}

Redeye Publicerad: 12 Feb 12:37

Redeye comments on Vertiseit’s Q4 report, with ARR and EBITDA-CAPEX roughly matching our expectations.

Länk till analysen i sin helhet: https://www.redeye.se/research/1074877/vertseit-q4-high-sales-and-cost-ebitda-capex-5-above-expectations?utm_source=finwire&utm_medium=RSS

Nyheter om Vertiseit

Läses av andra just nu

Om aktien Vertiseit

Senaste nytt